Stocks
H Lundbeck A/S Sponsored ADRHLUKY
YHDHealthcarePharmaceuticals
A Danish pharmaceutical company focused on brain disorders, including depression, schizophrenia, and Parkinson's disease. Its portfolio includes branded products like Trintellix and Rexulti, and it has a pipeline in neurology and psychiatry. Investors track the ADR for exposure to the global CNS therapeutics market.
Congressional Interest in H Lundbeck A/S Sponsored ADR (HLUKY)
1 member of Congress has disclosed 1 trade in H Lundbeck A/S Sponsored ADR (HLUKY), a Healthcare company. The buy/sell breakdown shows 0 purchases versus 1 sale, indicating net selling pressure from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
1
Unique Politicians
1
Buys
0
Sells
1
Who in Congress Is Trading HLUKY?
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2019-09-10 | Greg Gianforte | sell | $1K-$15K |